Vivus   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Mountain View CA United States (1991)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2004
NCT01616485
First Marketed Drug
2010
pancrelipase (creon)
First NDA Approval
2012
avanafil (stendra)
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

VIVUS | Vivus Clinical Research Department | VIVUS, Inc. | VIVUS INC